# Chinese Herbal Medicine Targets Gut Microbiota to Combat Neurodegenerative Diseases: Potential Mechanisms and Clinical Implications

**Authors:** Xi Yang, Yanling Qin, Wenxiu Mu, Wei Gao, Qi Chen, Jia Xia, Zhaozhao Huang

PMC · DOI: 10.4014/jmb.2510.10008 · 2026-02-25

## TL;DR

This paper reviews how Chinese herbal medicine may help treat neurodegenerative diseases by influencing gut microbiota and related biological processes.

## Contribution

The paper provides a comprehensive review of how Chinese herbal medicine interacts with gut microbiota to combat neurodegenerative diseases.

## Key findings

- Chinese herbal medicine can regulate gut microbiota diversity and probiotic abundance.
- CHM may reduce amyloid-beta deposition and oxidative stress in neurodegenerative diseases.
- CHM improves blood-brain barrier function through gut microbiota modulation.

## Abstract

Due to the aging of the population, neurodegenerative diseases (NDs) have gradually become a major public health problem worldwide. Accumulating evidence has demonstrated that the gut microbiota and its metabolites were closely related to the occurrence and development of NDs. At present, Chinese herbal medicine (CHM) is known for its multi-dimensional, multi-target, and multi-pathway approach in the prevention and treatment of various diseases by regulating the gut microbiota, and different CHMs can regulate the diversity of gut microbiota and the abundance of probiotics. Modern studies have also revealed that CHM possessed therapeutic effects against NDs by targeting gut microbiota, regulating the secretion of neuroactive metabolites, reducing amyloid-beta deposition and oxidative stress, and improving the function of the blood-brain barrier. Therefore, the dynamic interaction among CHM, gut microbiota, and NDs has become a research hotspot. This review elaborates on the research progress related to CHM, gut microbiota, and NDs, aiming to provide a new perspective and theoretical basis for the prevention of NDs by CHM administration.

## Full-text entities

- **Genes:** Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], Snca (synuclein, alpha) [NCBI Gene 20617] {aka NACP, alpha-Syn, alphaSYN}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Cdh1 (cadherin 1) [NCBI Gene 12550] {aka ARC-1, E-cad, Ecad, L-CAM, UVO, Um}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, Muc2 (mucin 2) [NCBI Gene 17831] {aka 2010015E03Rik, MCM, wnn}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}
- **Diseases:** move disorders (MESH:D009358), motor deficits (MESH:D009461), major depressive disorder (MESH:D003865), metabolic (MESH:D008659), obesity (MESH:D009765), neuroinflammation (MESH:D000090862), AD (MESH:D000544), ND (MESH:C537849), neurotoxic (MESH:D020258), dysbiosis (MESH:D064806), HD (MESH:D006816), PD (MESH:D010300), mitochondrial dysfunction (MESH:D028361), NDs (MESH:D019636), diseases (MESH:D004194), chronic inflammation (MESH:D007249), cognition impairment (MESH:D003072), movement disorder (MESH:D009069), MS (MESH:D009103), CHM (MESH:C562377), ADRD (MESH:D003704), enteric infections (MESH:D004751), neuronal damage (MESH:D009410), Dyskinesia (MESH:D004409), depressive (MESH:D003866), toxicity (MESH:D064420), gut and brain inflammation (MESH:D004660), spinocerebellar ataxia (MESH:D020754), lipid metabolism disorder (MESH:D052439), death (MESH:D003643), gut microbiota (MESH:C536735), ALS (MESH:D000690)
- **Chemicals:** ethanol (MESH:D000431), isovaleric acid (MESH:C008216), alkaloids (MESH:D000470), acetic acid (MESH:D019342), sinomenine (MESH:C009271), propionic acid (MESH:C029658), terpenes (MESH:D013729), tyrosine (MESH:D014443), Ginsenoside CK (MESH:C112772), polysaccharide (MESH:D011134), isobutyric acid (MESH:C020380), TMAO (MESH:C005855), GV-971 (MESH:C000710388), glucose (MESH:D005947), 5- hydroxytryptamine (MESH:D012701), flavonoids (MESH:D005419), BA (MESH:D001464), SCFA (MESH:D005232), berberine (MESH:D001599), saponin (MESH:D012503), dopamine (MESH:D004298), lysophosphatidylcholine (MESH:D008244), tryptophan (MESH:D014364), LPS (MESH:D008070), polyphenols (MESH:D059808), butyric acid (MESH:D020148), dopa (MESH:D004295), dioscin (MESH:C019357), piperine (MESH:C008922), pramipexole (MESH:D000077487), Oxymatrine (MESH:C037573), Icariin (MESH:C056599), Bushen capsule (-), donepezil (MESH:D000077265), bile acid (MESH:D001647)
- **Species:** Mediterraneibacter torques (species) [taxon 33039], Actinomycetota (actinobacteria, phylum) [taxon 201174], Clostridium butyricum (species) [taxon 1492], Agathobacter rectalis (species) [taxon 39491], Ganoderma lucidum (species) [taxon 5315], Bacteroides ovatus (species) [taxon 28116], Enterococcus faecalis (species) [taxon 1351], Veillonella parvula (species) [taxon 29466], Lactobacillus (genus) [taxon 1578], Helicobacteraceae (family) [taxon 72293], Prevotella (genus) [taxon 838], Stenotrophomonas (genus) [taxon 40323], Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562], Megamonas (genus) [taxon 158846], Anaerobutyricum hallii (species) [taxon 39488], Streptococcus mutans (species) [taxon 1309], Faecalibacterium (genus) [taxon 216851], Bacteroidia (class) [taxon 200643], Enterococcus faecium (species) [taxon 1352], Epimedium (genus) [taxon 63350], Pseudomonas (RNA similarity group I, genus) [taxon 286], Bifidobacterium bifidum (species) [taxon 1681], Oscillibacter (genus) [taxon 459786], Eleutherococcus senticosus (species) [taxon 82096], Enterobacteriaceae (enterobacteria, family) [taxon 543], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Faecalicatena fissicatena (species) [taxon 290055], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Prevotellaceae (family) [taxon 171552], Collinsella (genus) [taxon 102106], Akkermansia muciniphila (species) [taxon 239935]
- **Mutations:** A53T

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12975504/full.md

---
Source: https://tomesphere.com/paper/PMC12975504